-
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
University College London analyzed trends in AD and dementias to see if there are any trends among different ethnicities but information also indicated that diagnosis differs. This reminds us that diagnoses aren’t an exact standard protocol but the best efforts put by our healthcare teams. We have to work together to continue the push for…[Read more]
-
CarlsonTeke2 posted an update in the group Alzheimer’s Disease Advocate Network
This US-POINTER trial will test a 2-year multi-site and community-based multi domain intervention of physical activity, nutritional guidance, cognitive training and social activities, and management of medical co-morbidities for Alzheimer’s patients.
U.S. POINTER | Alzheimer's… -
CarlsonTeke2 posted an update in the group Alzheimer’s Disease Advocate Network
new data from the SPRINT MIND trial is an exciting first in our understanding of how aggressively treating systolic blood pressure could be part of a solution to treat Alzheimer’s.
Dementia & Blood Pressure | Blog | Alzheimer's… -
CarlsonTeke2 posted an update in the group Alzheimer’s Disease Advocate Network
Previous studies have shown changes to the brain as early as 10 to 20 years before the symptoms of Alzheimer’s Disease arise, but this body-worn sensors may help detect onset of Alzheimer’s disease.
Gait assessed with body-worn sensors may help detect onset of Alzheimer’s disease | Journal of Alzheimer's Dis… -
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
MiR-132, a micro RNA, may another neuroprotective molecule that clinicians and researchers can utilize for treatment giving clinical teams more avenues to attack AD.
Newly characterized molecule offers possibilities for novel Alzheimer's treatments –… -
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
The Alzheimer’s Prevention Registry is attempting to collect enough information to improve the diagnosis process for the future patients.
-
CarlsonTeke2 posted an update in the group Alzheimer’s Disease Advocate Network
Could this be the solution for Alzheimer’s Disease? =[L+MZ+Z+DHA+EPA] | Journal of Alzheimer's DiseaseShare Us: Subscribe | Contact -
CarlsonTeke2 posted an update in the group Alzheimer’s Disease Advocate Network
Deep Brain Stimulation showing promise for patients with mild Alzheimer’s disease over age 65 | Journal of Alzheimer's DiseaseShare Us: Subscribe | Contact -
Wilma Reyes joined the group
-
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
The potential dangers of the things that we often take granted like the air we breathe or in this case the water we drink, can be linked to brain damage that takes years to become clinically significant and therefore nearly impossible to pin down on. Animal research in Taiwan is indicating that ultrasound is a possible mitigator in protecting the…[Read more]
-
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
The liver may be playing a larger role in the development of AD. The influx of possibilities can be both overwhelming and exciting but it always comes back to the systems of the body being just parts to a larger whole.
A Gut–and Liver–Check to Get a Bead on Alzheimer's – Scientific… -
Aloha Health Network joined the group
-
LURINDA K joined the group
-
CarlsonTeke2 posted an update in the group Alzheimer’s Disease Advocate Network
Human trials of Alzheimer 'cure' | Express.co.ukTHE FIRST human trials of a ground-breaking drug shown to repair DNA damage that contributes to Alzheimer’s disease will be launched this week, in a move s… -
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
A multi-state study is recruiting to investigate whether Posiphen, which inhibits the formation of toxic plaques opposed to removing after formation, is a viable treatment.
400 Bad RequestYour browser sent a request that this… -
CarlsonTeke2 posted an update in the group Alzheimer’s Disease Advocate Network
New Alzheimer's drug may slow decline, researchers reportThe drug helped slow the inevitable loss of clear thinking and memory that comes with the condition. -
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
BAN2401, a new drug being developed by Biogen and Eisai shows exciting results in Phase 1 and Phase 2 trials with reduction of plaques and slowing the progression of AD by estimated 30%.…[Read more]
-
Suekopanke@comcast.bet joined the group
-
Suekopanke@comcast.bet joined the group Asperger’s Syndrome Advocate Network
-
llbruce joined the group
- Load More
